sacituzumab govitecan
gilead sciences
['bcsm', 'breast', 'tropics-02']
6/4 11:27am pt | breast cancer: will present primary results from a major clinical trial, tropics-02, for treatment of patients with hormone receptor positive/her2-negative (hr+/her2-) advanced breast cancer. #asco22 #bcsm 
Championing basic science, clinical research, epidemiology/cancer control, and patient care.
Contact: cancer-communications@ucsf.edu